2020 — Class action lawyers have reached a proposed Canada-wide settlement with the manufacturers of OxyContin® and OxyNEO®, to provide potential financial compensation options to individuals who have used the concerned prescription drugs (OxyContin® tablets and/or OxyNEO® tablets) and meet certain criteria to qualify for compensation.
There is no settlement or compensation process unless and until the proposed settlement is approved by the Courts. If the settlement is approved by the Courts, an individual “Claim Form” created and made available for individuals to apply for compensation, which must be signed and completed by you, in order to seek compensation.
The OxyNEO / OxyContin proposed class action settlement cannot take effect unless approved by the Canadian Courts. If this Canada-wide settlement is approved by the Courts, individuals who fall within the following “Class” definition, may be eligible to apply for individual compensation from the settlement fund:
- (i) All persons (including their estates) who at any time between January 1, 1996 and February 28, 2017 inclusive, were prescribed and ingested OxyContin® tablets and/or OxyNEO® tablets in Canada; or
- (ii) All persons who by virtue of a family relationship to a Class Member have a derivative claim under any derivative claim statute as a result of the death or personal injury of that class member.
Currently, the individual Claim Form process does not yet exist and no steps can to be taken by individuals wishing to apply for class action compensation at this time.
There is no need to contact our law office at the present time. Individual lawsuits are not being pursued by our law firm.
Class action litigation updates will be posted to this website AND you are encouraged to check for updates every six months (as well as providing your contact information below).
*** Please note, the OxyNEO / OxyContin proposed class action settlement only provides for potential financial compensation options to individuals who were legally prescribed OxyNEO or OxyContin. Our law firm is not pursuing any litigation regarding market black or street sales of these drugs. Also, no litigation is being pursued regarding the use or side effects of oxycodone. ***
POUR LE SERVICE EN FRANCAIS AU SUJET DE CE RECOURS COLLECTIF (OU D’AUTRE RECOURS POTENTIEL), S.V.P. CONTACTER NOTRE BUREAU DE MONTREAL MONTREAL@MERCHANTLAW.COM.
Merchant Law Group LLP has 10 offices across Canada, with lawyers practising law in six provinces. Merchant Law Group LLP and Tony Merchant, Q.C. are well known for pursuing class action lawsuits in Canada including litigation regarding Winners/HomeSense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools and various other cases. Tony Merchant, Q.C. is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.)
IF YOU WISH TO JOIN THE CONTACT LIST FOR THIS CLASS ACTION OR TO SIMPLY GET MORE INFORMATION, PLEASE COMPLETE THE BELOW FORM. (Please note, providing your information creates no financial obligation for you. You are not charged any fee or cost for joining this class action – we are simply paid a contingency fee from the compensation recovered, if successful.)